{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:53:04Z","timestamp":1784166784444,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00198-020-05579-7","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T16:06:08Z","timestamp":1596470768000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fracture risk assessment in celiac disease: a registry-based cohort study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-2722","authenticated-orcid":false,"given":"D.R.","family":"Duerksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.C.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3129-4326","authenticated-orcid":false,"given":"J.A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-1691","authenticated-orcid":false,"given":"W.D.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"5579_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl B, Sanders DS, Green PHR (2018) Coeliac disease. Lancet 391:70\u201381","journal-title":"Lancet"},{"key":"5579_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/gast.2003.50106","volume":"124","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Leslie WD, Leboff MS (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124:795\u2013841","journal-title":"Gastroenterology"},{"key":"5579_CR3","doi-asserted-by":"publisher","first-page":"198025","DOI":"10.1155\/2012\/198025","volume":"2012","author":"T Larussa","year":"2012","unstructured":"Larussa T, Suraci E, Nazionale I et al (2012) Bone mineralization in celiac disease. Gastroenterol Res Pract 2012:198025","journal-title":"Gastroenterol Res Pract"},{"key":"5579_CR4","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3390\/nu7053347","volume":"7","author":"P Grace-Farfaglia","year":"2015","unstructured":"Grace-Farfaglia P (2015) Bones of contention: bone mineral density recovery in celiac disease--a systematic review. Nutrients 7:3347\u20133369","journal-title":"Nutrients"},{"key":"5579_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/jc.2014-1858","volume":"100","author":"K Heikkila","year":"2015","unstructured":"Heikkila K, Pearce J, Maki M et al (2015) Celiac disease and bone fractures: a systematic review and meta-analysis. J Clin Endocrinol Metab 100:25\u201334","journal-title":"J Clin Endocrinol Metab"},{"key":"5579_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033\u20131046","journal-title":"Osteoporos Int"},{"key":"5579_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C et al (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25","journal-title":"Arch Osteoporos"},{"key":"5579_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1385\/JCD:6:3:275","volume":"6","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275\u2013282","journal-title":"J Clin Densitom"},{"key":"5579_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/JCD:8:1:025","volume":"8","author":"WD Leslie","year":"2005","unstructured":"Leslie WD, Caetano PA, Macwilliam LR et al (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25\u201330","journal-title":"J Clin Densitom"},{"key":"5579_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s13104-019-4693-2","volume":"12","author":"DR Duerksen","year":"2019","unstructured":"Duerksen DR, Lix LM, Leslie WD (2019) Development of an administrative definition for celiac disease. BMC Res Notes 12:661","journal-title":"BMC Res Notes"},{"key":"5579_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1515\/CCLM.2010.136","volume":"48","author":"P Toftedal","year":"2010","unstructured":"Toftedal P, Nielsen C, Madsen JT et al (2010) Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med 48:685\u2013691","journal-title":"Clin Chem Lab Med"},{"key":"5579_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1471-2458-12-301","volume":"12","author":"LM Lix","year":"2012","unstructured":"Lix LM, Azimaee M, Osman BA et al (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301","journal-title":"BMC Public Health"},{"key":"5579_CR13","first-page":"S275","volume":"33","author":"RAM Epp","year":"2018","unstructured":"Epp RAM, Ward L, Leslie WD (2018) Radiological validation of fracture definitions from administrative data. J Bone Miner Res 33:S275","journal-title":"J Bone Miner Res"},{"key":"5579_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bone.2006.02.002","volume":"39","author":"WD Leslie","year":"2006","unstructured":"Leslie WD (2006) The importance of spectrum bias on bone density monitoring in clinical practice. Bone 39:361\u2013368","journal-title":"Bone"},{"key":"5579_CR15","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/jbmr.123","volume":"25","author":"WD Leslie","year":"2010","unstructured":"Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25:2350\u20132358","journal-title":"J Bone Miner Res"},{"key":"5579_CR16","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1345\/aph.18117","volume":"32","author":"AL Kozyrskyj","year":"1998","unstructured":"Kozyrskyj AL, Mustard CA (1998) Validation of an electronic, population-based prescription database. Ann Pharmacother 32:1152\u20131157","journal-title":"Ann Pharmacother"},{"issue":"2","key":"5579_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jocd.2019.06.005","volume":"23","author":"D Micic","year":"2019","unstructured":"Micic D, Rao VL, Semrad CE (2019) Celiac disease and its role in the development of metabolic bone disease. J Clin Densitom 23(2):190\u2013199","journal-title":"J Clin Densitom"},{"key":"5579_CR18","unstructured":"Kanis J (2008) Assessment of osteoporosis at the primary health-care level. WHO Collaborating Centre, University of Sheffield, UK"},{"key":"5579_CR19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","volume":"50","author":"EM Dennison","year":"2012","unstructured":"Dennison EM, Compston JE, Flahive J et al (2012) Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 50:1288\u20131293","journal-title":"Bone"},{"key":"5579_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00223-013-9801-z","volume":"94","author":"JE Compston","year":"2014","unstructured":"Compston JE, Flahive J, Hooven FH et al (2014) Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW). Calcif Tissue Int 94:223\u2013231","journal-title":"Calcif Tissue Int"},{"key":"5579_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00198-016-3791-4","volume":"28","author":"E Kamycheva","year":"2017","unstructured":"Kamycheva E, Goto T, Camargo CA Jr (2017) Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey. Osteoporos Int 28:781\u2013790","journal-title":"Osteoporos Int"},{"key":"5579_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jocd.2017.05.010","volume":"21","author":"R Tortora","year":"2018","unstructured":"Tortora R, Imperatore N, Capone P et al (2018) FRAX score can be used to avoid superfluous DXA scans in detecting osteoporosis in celiac disease: accuracy of the FRAX score in celiac patients. J Clin Densitom 21:315\u2013321","journal-title":"J Clin Densitom"},{"key":"5579_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12891-016-1248-8","volume":"17","author":"L Cavalli","year":"2016","unstructured":"Cavalli L, Guazzini A, Cianferotti L et al (2016) Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. BMC Musculoskelet Disord 17:396","journal-title":"BMC Musculoskelet Disord"},{"key":"5579_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","volume":"63","author":"JF Ludvigsson","year":"2014","unstructured":"Ludvigsson JF, Bai JC, Biagi F et al (2014) Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 63:1210\u20131228","journal-title":"Gut"},{"key":"5579_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","volume":"7","author":"A Al-Toma","year":"2019","unstructured":"Al-Toma A, Volta U, Auricchio R et al (2019) European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J 7:583\u2013613","journal-title":"United European Gastroenterol J"},{"key":"5579_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ajg.2013.79","volume":"108","author":"A Rubio-Tapia","year":"2013","unstructured":"Rubio-Tapia A, Hill ID, Kelly CP et al (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108:656\u2013676 quiz 677","journal-title":"Am J Gastroenterol"},{"key":"5579_CR27","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ajg.2010.10","volume":"105","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia A, Rahim MW, See JA et al (2010) Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 105:1412\u20131420","journal-title":"Am J Gastroenterol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05579-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:20:20Z","timestamp":1627946420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05579-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5579"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05579-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Donald Duerksen: Nothing to declare in the context of this paper but has served as a consultant for Takeda and Abbvie.Lisa Lix: No conflicts of interest.Helena Johansson: No conflicts of interest.Eugene McCloskey: Nothing to declare for the context of this paper, but numerous ad hoc consultancies\/speaking honoraria and\/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS, and Warner-Chilcott.Nicholas Harvey: Nothing to declare for the context of this paper, but has received consultancy\/lecture fees\/honoraria\/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, Radius Health, UCB, Kyowa Kirin, and Internis Pharma.John A. Kanis: Nothing to declare in the context of this paper. Has received grants from Amgen, Lilly, and Radius Health.William Leslie: No conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the University of Manitoba Research Ethics Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This was a database study and therefore not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This was a database study and therefore not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}